| ALK | Anaplastic lymphoma kinase |
| BBB | Blood–brain barrier |
| BMs | Brain metastases |
| CNS | Central nervous system |
| DCR | Disease control rate |
| EGFR | Epidermal growth factor receptor |
| IC-ORR | Intracranial objective response rates |
| iDCR | Intracranial disease control rate |
| iORR | Intracranial objective response rate |
| iPFS | Intracranial progression-free survival |
| NSCLC | Non-small cell lung cancer |
| OS | Overall survival |
| PFS | Progression-free survival |
| SRS | Stereotactic radiosurgery |
| TKIs | Tyrosine kinase inhibitors |